Skip to main content
HR 2248 113th Congress House Health Administrative remedies Child health Department of Health and Human Services Food and Drug Administration (FDA) Food industry and services Food supply, safety, and labeling Hazardous wastes and toxic substances Product safety and quality Sex and reproductive health Water quality Women's health

Ban Poisonous Additives Act of 2013

Introduced: June 4, 2013 Introduced by: Markey, Edward J. Democratic · Massachusetts See on congress.gov
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jun 7, 2013
Referred to the Subcommittee on Health.
Jun 4, 2013
Referred to the House Committee on Energy and Commerce.
Jun 4, 2013
Introduced in House
 Plain-English summary Congressional Research Service

Ban Poisonous Additives Act of 2013 - Prohibits the distribution of a food if its container is composed, in whole or in part, of bisphenol A (BPA) or can release BPA into food. 

Authorizes the Secretary of Health and Human Services (HHS) to grant one-year renewable waivers to a facility for a particular container if such facility: (1) demonstrates that it is not technologically feasible to replace BPA in the container or to use an alternative container that does not contain BPA, and (2) submits to the Secretary a plan and timeline for removing BPA from such container. Sets forth labeling requirements for a product granted a waiver.

Requires the Commissioner of Food and Drugs (FDA) to review substances in order determine whether there is a reasonable certainty that no harm will result from aggregate exposure to such substance, taking into consideration potential adverse effects from low dose exposure and the effects on vulnerable populations and populations with high exposure. Sets forth remedial actions based on the Secretary's determination.

Amends the Federal Food, Drug, and Cosmetic Act to require a manufacturer or supplier of a food contact substance to notify the Secretary of the identity and intended use of any such substance prior to its introduction into interstate commerce and of its determination that: (1) no adverse health effects result from low-dose exposures to such substance; and (2) such substance has not been shown, after tests which are appropriate for the evaluation of the safety of food contact substances, to cause reproductive or developmental toxicity in humans or animals.

What's happening now June 7, 2013

Referred to the Subcommittee on Health.

 Committees of jurisdiction 2